It is not always a smooth ride when a company is navigating the acquisition and fusion of disparate cultures, specialties, and other variables from formerly separate organizations. But the process can bring a hybrid vigor when new professionals are integrated into one's corporate family. Just as the science of clinical trials benefits from patient diversity, so does the workforce and the broader industry.
